In sum, the 5xFAD brain, at a time point of advanced AD pathology (but prior to neurodegeneration), is significantly more vulnerable to the neurotoxicity of the TLR2 agonist than wild-type brains. The gene discussed is TLR2; the disease is Alzheimer disease.